CA2370646A1 - Nucleic acid immunization - Google Patents

Nucleic acid immunization Download PDF

Info

Publication number
CA2370646A1
CA2370646A1 CA002370646A CA2370646A CA2370646A1 CA 2370646 A1 CA2370646 A1 CA 2370646A1 CA 002370646 A CA002370646 A CA 002370646A CA 2370646 A CA2370646 A CA 2370646A CA 2370646 A1 CA2370646 A1 CA 2370646A1
Authority
CA
Canada
Prior art keywords
nucleic acid
use according
sequence
particles
polysaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002370646A
Other languages
English (en)
French (fr)
Inventor
Dexiang Chen
James T. Fuller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Powderject Vaccines Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2370646A1 publication Critical patent/CA2370646A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6075—Viral proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
CA002370646A 1999-04-21 2000-04-21 Nucleic acid immunization Abandoned CA2370646A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13024999P 1999-04-21 1999-04-21
US60/130,249 1999-04-21
PCT/US2000/010766 WO2000063385A2 (en) 1999-04-21 2000-04-21 Nucleic acid immunization

Publications (1)

Publication Number Publication Date
CA2370646A1 true CA2370646A1 (en) 2000-10-26

Family

ID=22443785

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002370646A Abandoned CA2370646A1 (en) 1999-04-21 2000-04-21 Nucleic acid immunization

Country Status (6)

Country Link
EP (1) EP1180150A2 (de)
JP (1) JP2002542264A (de)
AU (1) AU4479700A (de)
CA (1) CA2370646A1 (de)
NZ (1) NZ515041A (de)
WO (1) WO2000063385A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004535358A (ja) * 2000-11-02 2004-11-25 パウダージェクト ワクチンズ，インコーポレーテッド 核酸免疫
EP1671655A4 (de) * 2003-08-29 2009-08-12 Anges Mg Inc Gentherapie für hauterkrankungen mit nadelfreier spritze
WO2006027244A2 (en) * 2004-09-10 2006-03-16 Bracco Imaging S.P.A. Paramagnetic metal polyamino complexes for mri visualization of internalized polynucleotides
WO2006133497A1 (en) * 2005-06-15 2006-12-21 Adelaide Research & Innovation Pty Ltd Combination treatment
WO2007087758A2 (es) * 2006-01-31 2007-08-09 Centro De Ingenieria Genetica Y Biotecnologia Mimotopos de polisacáridos capsulares de neisseria meningitidis y formulaciones farmacéuticas
WO2008043157A1 (en) 2006-10-12 2008-04-17 The University Of Queensland Compositions and methods for modulating immune responses
AU2011325857A1 (en) 2010-11-01 2013-05-02 University Of Technology, Sydney Immune-modulating agents and uses therefor
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
US11541110B2 (en) 2017-10-13 2023-01-03 The Research Foundation For The State University Of New York Comprehensive vaccine design for commensal disease progression

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994027435A1 (en) * 1993-06-01 1994-12-08 Life Technologies, Inc. Genetic immunization with cationic lipids
CA2158733C (en) * 1994-01-21 2007-01-16 Dennis E. Mccabe Gas driven gene delivery instrument
WO1997011605A1 (en) * 1995-09-28 1997-04-03 University Of Pittsburgh Of The Commonwealth System Of Higher Education Stimulation of cell-mediated immune responses by targeted particulate genetic immunization
GB9609125D0 (en) * 1996-05-01 1996-07-03 Smithkline Beecham Plc Novel compounds
US6204250B1 (en) * 1996-11-22 2001-03-20 The Mount Sinai Medical Center Of The City Of New York Immunization of infants

Also Published As

Publication number Publication date
EP1180150A2 (de) 2002-02-20
AU4479700A (en) 2000-11-02
JP2002542264A (ja) 2002-12-10
WO2000063385A2 (en) 2000-10-26
WO2000063385A3 (en) 2001-02-22
NZ515041A (en) 2004-03-26

Similar Documents

Publication Publication Date Title
Ellis New technologies for making vaccines
ES2337017T3 (es) Procedimiento para obtener respuestas inmunitarias celulares de proteinas.
ES2670196T3 (es) Disolución de polisacáridos capsulares y vacunas de combinación
ES2523365T3 (es) Expresión híbrida y en tandem de proteínas de Neisseria
JP5670003B2 (ja) 血清型ＢおよびＣ由来のＮｅｉｓｓｅｒｉａｍｅｎｉｎｇｉｔｉｄｉｓ抗原、ならびにさらなる抗原を含む組成物
BRPI0609460A2 (pt) haemophilus influenzae tipo b
JP4646516B2 (ja) 吸着したポリペプチド含有分子を有する微粒子
MXPA01009452A (es) Vacuna.
CA2370646A1 (en) Nucleic acid immunization
EP1379273B1 (de) Nukleinsäureadjuvantien
US20050226846A1 (en) Nucleic acid vaccine compositions having a mammalian CD80/CD86 gene promoter driving antigen expression
AU2001297988A1 (en) Nucleic acid adjuvants
US20070237789A1 (en) DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
US8034349B2 (en) Peptides that mimic non-human cross-reactive protective epitopes of the group B meningococcal capsular polysaccharide
US20040082530A1 (en) Nucleic acid immunization
ZA200503377B (en) Nucleic acid constructs for gene expression
US20050148529A1 (en) Nucleic acid immunization
AU785066B2 (en) DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
WO2001083528A2 (en) Nucleic acid immunization
US20060019921A1 (en) Nucleic acid adjuvants
JP2004522403A (ja) 抗原発現を駆動する哺乳動物ｃｄ８０／ｃｄ８６遺伝子プロモーターを有する核酸ワクチン組成物
MXPA01009455A (en) Vaccine

Legal Events

Date Code Title Description
FZDE Dead